Conmed (CNMD) Azione Prezzo
Conmed Prezzo
Negli ultimi 19 anni Conmed ha aumentato il fatturato del 4,0% all'anno, raggiungendo 1,37 miliardi USD. L'utile per azione è cresciuto del 0,3% all'anno negli ultimi 18 anni. Per Conmed, il margine netto del 3,4% risulta in calo rispetto al 6,2% di alcuni anni fa. Al prezzo attuale il rendimento da dividendo è pari a circa il 1,34%. Il payout ratio è pari a circa il 40% degli utili. Il target di prezzo di consenso a 12 mesi per Conmed è 37,50 USD, circa il 16,1% sotto il prezzo attuale di mercato. Su 12 analisti, 0 valutano il titolo come acquisto — nel complesso un consenso Mantenere.
Conmed Prezzo delle azioni
Conmed Azione e analisi azionaria
Domande frequenti sull'azione Conmed
Conmed Corp is a leading global medical technology company. Its business model revolves around offering a wide range of surgical products and services to healthcare professionals worldwide. The company specializes in the development, manufacturing, and marketing of innovative surgical devices and equipment. With a focus on minimally invasive procedures, Conmed Corp aims to enhance patient outcomes and reduce healthcare costs. By providing solutions for areas such as electrosurgery, endosurgery, and orthopedic surgery, Conmed Corp continues to drive advancements in the medical field. This commitment to delivering high-quality products and advancing medical technologies solidifies its position as a trusted industry leader.
Conmed Corp is primarily active in the medical devices industry.
The main competitors of Conmed Corp in the market include Medtronic, Johnson & Johnson, Stryker Corporation, and Smith & Nephew.
Conmed Corp. is a renowned medical technology company with a rich history and strong background. Founded in 1970, Conmed Corp. has been dedicated to providing innovative surgical solutions and equipment to healthcare professionals worldwide. With its headquarters in Utica, New York, the company has grown to become a leading player in the field of minimally invasive procedures. Conmed Corp. offers a wide range of products, including surgical instruments, endoscopic technologies, and electrosurgical systems, designed to enhance patient outcomes and streamline healthcare processes. With a focus on research and development, Conmed Corp. continues to shape the future of surgical advancements and improve the standard of patient care.
Conmed Corp has achieved several significant milestones throughout its history. The company has successfully established itself as a leading global medical technology provider, specializing in surgical devices and equipment. Conmed Corp has expanded its product portfolio and enhanced its research and development efforts to cater to a wide range of medical specialties. The company has also received numerous accolades and recognition for its innovative solutions and commitment to improving patient outcomes. With its relentless dedication to advancing clinical education and training, Conmed Corp has become a trusted name in the healthcare industry, ensuring enhanced surgical techniques and superior patient care.
Conmed Corp is primarily present in various countries and regions across the globe. The company has a significant presence in the United States, where its headquarters is located. Additionally, Conmed Corp has established a strong market presence in Europe, especially in countries like Germany, France, and the United Kingdom. The company also operates in Asian markets, including China and Japan, and has a growing presence in emerging markets such as India and Brazil. Furthermore, Conmed Corp has a global distribution network, allowing its products and services to reach healthcare facilities worldwide.
Conmed Corp represents a commitment to delivering innovative medical solutions. With a strong corporate philosophy centered around the core values of integrity, quality, and customer focus, the company aims to improve patient outcomes. Conmed Corp is dedicated to maintaining high ethical standards, fostering a culture of continuous improvement, and promoting teamwork and collaboration. By combining cutting-edge technology with a patient-centric approach, Conmed Corp strives to provide healthcare professionals with advanced tools and services that address the evolving needs of the medical community.
Gli analisti fissano attualmente un prezzo obiettivo medio di 37,50 USD per l’azione Conmed (mediana: 37,50 USD), pari a -16,1 % rispetto all’ultimo prezzo. Il consenso si basa su 12 giudizi di analisti.
12 analisti valutano attualmente l’azione Conmed: 0 raccomandano l’acquisto, 8 la tenuta e 4 la vendita. Per il 2026 gli analisti si aspettano per Conmed ricavi pari a 1,37 miliardi USD e un utile per azione di 4,55 USD.
Convertita al tasso di cambio attuale, l’azione Conmed quota 39,92 EUR (44,69 USD).
L’azione Conmed (CNMD) è quotata su 5 borse, tra cui: NYSE (CNMD), SIX (Zürich) (EC8.SW), Frankfurt (EC8.F), München (EC8.MU), Düsseldorf (EC8.DU).
Conmed Corporation is a multinational provider of medical devices and instruments used in orthopedics, gastroenterology, endoscopy, laparoscopy, and other medical fields. The company is headquartered in Utica, New York, and operates in more than 30 countries. Conmed has a diverse business segment that focuses on three main categories: Surgical Instruments, Endoscopy, and Electrosurgery. These three divisions offer various products tailored to the specific needs of surgeons and other medical professionals. The Surgical Instruments division includes a wide range of products such as scissors, forceps, needle holders, scalpels, retractors, and other specialized surgical instruments. These instruments are used in a variety of surgical procedures to ensure precision and safety. Endoscopy is an increasingly important field of study in medicine. Here, Conmed offers a range of products such as endoscopes, capsule endoscopes, endoscopic ultrasound probes, and endoscopy accessories. Endoscopes allow doctors to examine internal organs and tissues, reducing the costs and risks associated with traditional surgery. The Electrosurgery division includes products such as generators, active electrodes, monopolar instruments, bipolar instruments, and accessories. Electrosurgery is used in many surgical procedures to cut, coagulate, or remove tissue. Conmed's products enable surgeons to quickly and effectively remove tissue without causing damage to healthy tissue. Conmed's products are used by a variety of medical professionals in various medical fields. The company also provides excellent customer support, ensuring that surgeons and medical professionals can receive assistance at any time. Conmed has introduced the following products on the market: - Hall Zimmer Surgical PowerTools: The system offers electrically powered surgical hand drills, saws, grinders, and other surgical instruments for orthopedics. - Edge Bipolar Clamping System: This is a bipolar instrument system with a universal cable that can be used in many different surgical procedures. - PRO360 Digital Laparoscopy System: A complete endoscopic device system that provides clear, high-resolution imaging for laparoscopy. - EndoRotor Medical Endoscopy Cleaner: This device allows endoscopy systems to be cleaned, disinfected, and sterilized in a simpler and more effective way. Conmed has a robust service and support system aimed at maintaining customer trust and loyalty. Furthermore, Conmed continuously strives to acquire new knowledge and improve its technology to provide surgeons and other medical professionals with the best instruments and products to enhance their success rate and patient outcomes. Overall, Conmed has a first-class business model that helps medical professionals make their work more effective and safer. The company puts its expertise and technology at the service of the healthcare community and is committed to the safety of its customers and their patients. Answer: Conmed Corporation is a multinational provider of medical devices and instruments used in various medical fields such as orthopedics, gastroenterology, and endoscopy. The company focuses on three main categories: Surgical Instruments, Endoscopy, and Electrosurgery. They offer a wide range of products tailored to the specific needs of surgeons and other medical professionals. Conmed aims to provide reliable customer support and continuously improve their technology to enhance the success and safety of medical procedures.
Il attesa fatturato di Conmed ammonta a 1,37 miliardi USD. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il attesa profitto di Conmed ammonta a 141,28 Mio. USD. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di Conmed è attualmente 9,81. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione Conmed.
Il rapporto prezzo/fatturato (P/S) di Conmed è attualmente 1,01. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione Conmed.
Il Quality Score AlleAktien per Conmed è 5/10.
L'ISIN di Conmed è US2074101013. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il WKN di Conmed è 886793. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.
Il ticker di Conmed è CNMD. Con questo simbolo di borsa vengono negoziate le azioni Conmed in borsa.
Azione Conmed
Gruppo di pari di Conmed
Conmed Ticker
Conmed FIGI
Altre metriche e analisi di Conmed in Deep Dive.
La nostra analisi azionaria dell'azione Conmed include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di Conmed. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: